THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES
In the last ten years, a consistent number of clinical studies have evaluated different gene approaches for the treatment of patients with sickle cell disease (SCD) and transfusion-dependent b-thalassemia (TDT). Initial studies of gene therapy for hemoglobinopathies involved the use of lentiviral v...
Saved in:
Main Authors: | Ugo Testa, Giuseppe Leone, Maria Domenica Cappellini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2024-08-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://www.mjhid.org/mjhid/article/view/5768 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Red blood cell indices in different hemoglobinopathies: A cross-sectional study in Eastern India
by: Ayandip Nandi, et al.
Published: (2022-10-01) -
Prevalence and spectrum of haemoglobinopathies in females of reproductive age group- A first tertiary care center experience in Punjab, North India
by: Vikram Narang, et al.
Published: (2023-07-01) -
Studying Some Factors That Increase the Risk of Thalassemia in The City of Baquba
by: Sara Fawzi Sahm
Published: (2022-11-01) -
Comparison of Asymptomatic Brain Lesions Between Thalassemia Major and Sickle Cell Anemia Patients
by: Derya Yavuz Demiray, et al.
Published: (2025-01-01) -
Promising role of voxelotor in managing sickle cell disease in children: a narrative review
by: Amit Agrawal, et al.
Published: (2025-02-01)